Back

Adverse prognostic implications of increased left ventricular force in hypertrophic cardiomyopathy

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Specific underlying diseases of heart failure Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Karina Wierzbowska-Drabik

Medical University of Lodz, Lodz (Poland)

7 More presentations in this session

Presentation thumbnail
Prognostic impact of myocarditis as aetiology compared with dilated cardiomyopathy and ischaemic heart disease in heart failure
Professor M. Fu (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Time-varying cox model for heart failure prediction in phospholamban p.(Arg14del)-positive individuals
Miss M. Van Der Heide (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Hyponatremia and risk of new-onset heart failure in patients with type 2 diabetes - a real-world study of 70,000 patients
Doctor M. Jensen (Herlev, DK)
Abstract Slides Video
Presentation thumbnail
Clinical and genetic profiles of patients with hereditary and wild type transthyretin amyloidosis: the transthyretin cardiac amyloidosis registry in the state of Sao Paulo, Brazil REACT-SP
Assistant Professor F. Fernandes (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Is the incidence of cerebral embolic events underestimated in Takotsubo cardiomyopathy?
Doctor M. Ilinca (Sherbrooke, CA)
Abstract Slides Video

Access the full session

Session thumbnail
Specific underlying diseases of heart failure

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Non-invasive assessment of left ventricular hemodynamic forces in hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Prognostic role of the progression of late gadolinium enhancement in hypertrophic cardiomyopathy.
thumbnail
Congress Presentation
Unfavorable systemic and coronary hemodynamic profile of left ventricular hypercontractile phenotype in hypertrophic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources